27340777|t|Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
27340777|a|The orphan G protein-coupled receptor GPR55 has been directly or indirectly related to basic alterations that drive malignant growth: uncontrolled cancer cell proliferation, sustained angiogenesis, and cancer cell adhesion and migration. However, little is known about the involvement of this receptor in metastasis. Here, we show that elevated GPR55 expression in human tumors is associated with the aggressive basal / triple-negative breast cancer population, higher probability to develop metastases, and therefore poor patient prognosis. Activation of GPR55 by its proposed endogenous ligand lysophosphatidylinositol confers pro-invasive features on breast cancer cells both in vitro and in vivo. Specifically, this effect is elicited by coupling to Gq/11 heterotrimeric proteins and the subsequent activation, through ERK, of the transcription factor ETV4 / PEA3. Together, these data show that GPR55 promotes breast cancer metastasis, and supports the notion that this orphan receptor may constitute a new therapeutic target and potential biomarker in the highly aggressive triple-negative subtype.
27340777	18	39	orphan receptor GPR55	T103	UMLS:C2002138
27340777	43	67	lysophosphatidylinositol	T103	UMLS:C0065391
27340777	77	87	metastasis	T038	UMLS:C0027627
27340777	91	120	triple-negative breast cancer	T038	UMLS:C3539878
27340777	125	158	orphan G protein-coupled receptor	T103	UMLS:C0682972
27340777	159	164	GPR55	T103	UMLS:C2002138
27340777	247	253	growth	T038	UMLS:C0018270
27340777	275	293	cell proliferation	T038	UMLS:C0596290
27340777	295	317	sustained angiogenesis	T038	UMLS:C0302600
27340777	330	343	cell adhesion	T038	UMLS:C0007577
27340777	414	422	receptor	T103	UMLS:C0597357
27340777	426	436	metastasis	T038	UMLS:C0027627
27340777	486	491	human	T204	UMLS:C0086418
27340777	492	498	tumors	T038	UMLS:C0027651
27340777	522	538	aggressive basal	T038	UMLS:C0027671
27340777	541	570	triple-negative breast cancer	T038	UMLS:C3539878
27340777	571	581	population	T098	UMLS:C1257890
27340777	613	623	metastases	T038	UMLS:C0027627
27340777	652	661	prognosis	T058	UMLS:C0033325
27340777	677	682	GPR55	T103	UMLS:C2002138
27340777	710	716	ligand	T103	UMLS:C0023688
27340777	717	741	lysophosphatidylinositol	T103	UMLS:C0065391
27340777	775	794	breast cancer cells	T017	UMLS:C1512505
27340777	813	820	in vivo	T082	UMLS:C1515655
27340777	875	904	Gq/11 heterotrimeric proteins	T103	UMLS:C2975447
27340777	944	947	ERK	T103	UMLS:C0600388
27340777	956	981	transcription factor ETV4	T103	UMLS:C1333479
27340777	984	988	PEA3	T103	UMLS:C0084827
27340777	1021	1026	GPR55	T103	UMLS:C2002138
27340777	1036	1049	breast cancer	T038	UMLS:C0678222
27340777	1050	1060	metastasis	T038	UMLS:C0027627
27340777	1096	1111	orphan receptor	T103	UMLS:C0597357
27340777	1166	1175	biomarker	T201	UMLS:C0005516
27340777	1190	1224	aggressive triple-negative subtype	T170	UMLS:C1519691